mTOR as a Potential Target for the Prevention and Treatment of Hepatocellular Carcinoma

E-ISSN： 1873-5576|12|9|1045-1061

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.12, Iss.9, 2012-11, pp. : 1045-1061

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

mTOR, a Potential Target to Treat Autism Spectrum Disorder

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 15, Iss. 5, 2016-05 ,pp. : 533-543

Bentham Science Publishers

Access to resources Recommend Favorite

mTOR inhibitors in the treatment of cancer

By Fasolo Angelica Sessa Cristiana

Expert Opinion on Investigational Drugs, Vol. 17, Iss. 11, 2008-11 ,pp. : 1717-1734

Informa Healthcare

Access to resources Recommend Favorite

Mammalian Target of Rapamycin (mTOR) Inhibitors: Potential Uses and a Review of Haematological Adverse Effects

By Sofroniadou Sofia Goldsmith David

Drug Safety, Vol. 34, Iss. 2, 2011-02 ,pp. : 97-115

Adis International

Access to resources Recommend Favorite

The mTOR protein as a target in thyroid cancer

By Souza Elaine Cristina Lima de Ferreira Andrea Claudia Freitas Carvalho Denise Pires de

Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 9, 2011-09 ,pp. : 1099-1112

Informa Healthcare

Access to resources Recommend Favorite

An overview of the mTOR pathway as a target in cancer therapy

By Gentzler Ryan D Altman Jessica K Platanias Leonidas C

Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 5, 2012-05 ,pp. : 481-489

Informa Healthcare

Access to resources Recommend Favorite